Can Price Transparency Contribute to More Affordable Patient Access to Medicines? - Wikidata - wikimedia - TriplyDB

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

http://www.wikidata.org/entity/Q47099148

about

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

http://www.wikidata.org/entity/Q47099148

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

@en

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

@nl

type

label

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

@en

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

@nl

prefLabel

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

@en

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

@nl

P1433

Q47099148-8D326E22-F2F6-4948-9AF4-920D2E1B434B

P1476

Q47099148-F7754B3A-D32F-40AB-BF9C-C3F1594C39BD

P2093

Q47099148-B31E1D96-F321-4BC9-A952-8B58AC39C20E

P2860

Q47099148-03346EC3-EDAA-4C8E-99CA-DB39FD3ECAD3

Q47099148-428CEE9B-37C5-42FB-91DC-C10083309054

Q47099148-451CC59E-3354-46C5-843B-C74C576E7AD1

Q47099148-6820BD7B-4865-4623-B492-8D08403AE91A

Q47099148-881CC1F3-99D4-4A64-921D-AD5C796E30AA

Q47099148-EFBD1811-13C7-48EA-B236-EC166715759A

P2888

Q47099148-EF800D53-7F1D-4EF3-BEA7-7E79A49B1B13

P304

Q47099148-671F3FC8-AA37-44A9-A134-640808028740

P31

Q47099148-39a9f72a-9ae0-4a4b-b6c6-71f7219c10af

Q47099148-B70B0589-E209-4E8F-868C-CE90A17CAE19

P356

Q47099148-CA58B8CE-5000-4D9F-B843-287F5917B5D5

P433

Q47099148-B8C0C238-314C-4707-B10B-10CB6C3C6656

P478

Q47099148-756D2D99-30A0-47B9-B47F-B9DC759163C8

P50

Q47099148-F19ECEFC-1D16-4FA8-8261-A41D8FF9A9B9

P577

Q47099148-03290DB1-794B-4556-BAF4-28F1098955E9

P698

Q47099148-CB09BC17-D901-45F4-BCF2-DBAEB0D8D2B1

P932

Q47099148-029CDD5F-7734-49C6-908D-23D5C9C1556E

P356

S41669-017-0028-1

P1433

PharmacoEconomics - Open

P1476

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

@en

P2093

Kenneth R Paterson

http://www.w3.org/2001/XMLSchema#string

P2860

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question.

Differential pricing of new pharmaceuticals in lower income European countries.

How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.

Payers' experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia.

P2888

s41669-017-0028-1

P304

145-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S41669-017-0028-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29441499

http://www.w3.org/2001/XMLSchema#string

P932

5691843

http://www.w3.org/2001/XMLSchema#string